Stacie Woods

FDA investigator

Appears on 7 documents from 2016 to 2020, most often at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

7
Documents on file
2.6
Observations per 483
2016
First seen
2020
Most recent

What they cite most

From 18 observations

Activity by year

2016: 2, 2017: 4, 2020: 1

Where

India 3 · Virginia 2 · California 1 · Maryland 1

Often inspects with

Lata Mathew· Djamila Harouaka· Haijing Hu

Is Stacie Woods coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 MedPark Pharmacy, LLCMar 9, 2020 · Annapolis, Maryland
483 MSN LIFE SCIENCES PRIVATE LIMITEDJun 30, 2017 · Medak, India
483 Dr Reddy's Laboratories Limited FTO-SEZ Unit 1, Surv. 59-60, 62 & 72Jun 16, 2017 · Ranashthalam Mandal, India
483 Dr Reddy’s Laboratories LimitedJun 16, 2017 · Ranashthalam Mandal, Srikakulam, India
483 J.W. Platt, RPh LLC., dba The Wellness PharmacyMay 16, 2017 · Winchester, Virginia
483 RX South DBA RX3 Compounding Pharmacy LLCMay 6, 2016 · Chester, Virginia
483 Central Admixture Pharmacy Services, Inc.Feb 5, 2016 · Irvine, California

About this profile

What does Stacie Woods inspect?

Stacie Woods appears on 7 documents on file covering 6 sites, most often in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.67 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Stacie Woods is dated Mar 9, 2020.